Latest News
-
‘What Happens Three Months From Now?’ Mental Health After Georgia High School Shooting
-
The First Year of Georgia’s Medicaid Work Requirement Is Mired in Red Tape
-
No One Wants To Talk About Racial Trauma. Why My Family Broke Our Silence.
-
KFF Health News' 'What the Health?': Trump-Harris Debate Showcases Health Policy Differences
-
Over 57 Million Could Be Clinically Eligible for GLP-1 Drugs
Over two in five (57.4 million) adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues.
-
First-Ever Government Negotiation Process for Drugs
This post for Health Affairs Forefront examines how the results of the first-ever Medicare drug price negotiations will generate savings for the government and for Medicare beneficiaries, and how candidates’ views on the issue could play a role in the upcoming elections and in the future of government negotiation.
-
Vaccine Misinformation Spreads as Kids Head Back to School
In this installment of the Health Misinformation Monitor, vaccine hesitancy and misinformation around MMR (measles, mumps, and rubella) vaccines as children return to school. Plus COVID-19 vaccine misinformation and false claims about mpox.
-
Beyond the Data by Drew Altman
In his regular Beyond the Data columns, CEO Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.